USE OF CRAC INHIBITORS AND CYSTEINYL LEUKOTRIENE INHIBITORS FOR TREATING ALLERGY AND ASTHMA

摘要

The present disclosure provides methods, uses and products for use in treating disorders associated with mast cell activation. The present disclosure includes for example combinations of agents which inhibit Calcium Release Activated Calcium (CRAC) channels and agents which inhibit leukotriene activation of mast cells for use in treating disorders including allergic rhinitis and nasal polyposis.